Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
Market Analysis and Insights: Global Active Pharmaceutical Ingredient (API) Market
The global Active Pharmaceutical Ingredient (API) market was valued at US$ 67700 in 2020 and will reach US$ 99230 million by the end of 2027, growing at a CAGR of 6.6% during 2022-2027.
Global Active Pharmaceutical Ingredient (API) Scope and Market Size
The global Active Pharmaceutical Ingredient (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredient (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Anti-Infective
Hormonal
Others
Segment by Application
Respiratory
Rheumatology
Diabetes
Oncology
Others
The Active Pharmaceutical Ingredient (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Active Pharmaceutical Ingredient (API) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Market Analysis and Insights: Global Active Pharmaceutical Ingredient (API) Market
The global Active Pharmaceutical Ingredient (API) market was valued at US$ 67700 in 2020 and will reach US$ 99230 million by the end of 2027, growing at a CAGR of 6.6% during 2022-2027.
Global Active Pharmaceutical Ingredient (API) Scope and Market Size
The global Active Pharmaceutical Ingredient (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredient (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Anti-Infective
Hormonal
Others
Segment by Application
Respiratory
Rheumatology
Diabetes
Oncology
Others
The Active Pharmaceutical Ingredient (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Active Pharmaceutical Ingredient (API) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
